Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 9/20 | 0.52 |
| ▸ | GNPAT | O15228 | 1/20 | 0.46 |
| ▸ | ALB | P02768 | 2/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | GLP1R | P43220 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25358482 | 1.00 | FOLH1 (0.52) | FOLH1GNPATALBNOD1GLP1R | |
| SCHEMBL31688586 | 0.92 | FOLH1 (0.51) | FOLH1ALBNOD1GLP1REPHX2 | |
| SCHEMBL20900403 | 0.91 | EPHX2 (0.51) | FOLH1ALBNOD1GLP1REPHX2 | |
| SCHEMBL20900398 | 0.91 | EPHX2 (0.51) | FOLH1ALBNOD1GLP1REPHX2 | |
| SCHEMBL14118084 | 0.90 | FOLH1 (0.46) | FOLH1ALBNOD1GLP1RALDH1A1 | |
| SCHEMBL14118034 | 0.90 | FOLH1 (0.51) | FOLH1ALBNOD1GLP1RALDH1A1 | |
| SCHEMBL16882583 | 0.89 | NOD1 (0.51) | FOLH1ALBNOD1GLP1REPHX2 | |
| SCHEMBL24709112 | 0.89 | FOLH1 (0.48) | FOLH1GNPATALBALDH1A1EPHX2 | |
| SCHEMBL8280997 | 0.89 | FOLH1 (0.48) | FOLH1GNPATALBALDH1A1EPHX2 | |
| SCHEMBL25357657 | 0.87 | NAAA (0.53) | FOLH1ALBNOD1GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | claimed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | FOLH1 145/4885GNPAT 1953/4885ALB 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.